Giant Biogene Holding Co., Ltd.
2367
Clasificación en acciones
#5019
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Precio por acción
$2.67
Capitalización bursátil
$2.84B
Cambio (1 día)
-6.09%
Cambio (1 año)
-46.20%
País
CN
Comercio Giant Biogene Holding Co., Ltd. (2367)
Categoría
Consumer Defensive
Historial de dividendos de Giant Biogene Holding Co., Ltd. (2367)
Giant Biogene Holding Co., Ltd. (símbolo bursátil: 2367) realizó un total de 3 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: $3.67
Rentabilidad por dividendo (TTM): 0.0662
La suma de todos los dividendos (ajustados por splits de acciones) es: $3.67
Rentabilidad por dividendo (TTM): 0.0662
Pagos de dividendos de Giant Biogene Holding Co., Ltd. (2367) desde 2024 hasta 2026
Pagos anuales de dividendos
| Año | Dividendo (ajustado por splits de acciones) | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.39 | 6.39% |
| 2025 | $1.31 | 34.63% |
| 2024 | $0.97 | 0.00% |
Lista de todos los pagos de dividendos
| Año | Dividendo | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.39 | 6.39% |
| 2025 | $1.31 | 34.63% |
| 2024 | $0.97 | 0.00% |
Pagos de dividendos de empresas similares o competidoras
| Empresa | Número de pagos de dividendos | País |
|---|---|---|
| 229.00% |
US
|
|
| 27.00% |
FR
|
|
| 214.00% |
US
|
|
| 60.00% |
IN
|
|
| 91.00% |
US
|
